Highlights
- •α-Synuclein accumulation induces ER fragmentation in patient-derived midbrain neurons
- •α-Synuclein perturbs the neuron's ability to recognize and respond to misfolded proteins in the ER
- •Parkinson's neurons develop pathogenic aggregates of immature lysosomal GCase
- •GCase solubility/function is rescued by enhancing ER folding and downstream trafficking
Summary
Graphical abstract
Keywords
Introduction
- Chang D.
- Nalls M.A.
- Hallgrímsdóttir I.B.
- Hunkapiller J.
- van der Brug M.
- Cai F.
- Kerchner G.A.
- Ayalon G.
- Bingol B.
- Sheng M.
- et al.
A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci.
- Nalls M.A.
- Pankratz N.
- Lill C.M.
- Do C.B.
- Hernandez D.G.
- Saad M.
- DeStefano A.L.
- Kara E.
- Bras J.
- Sharma M.
- et al.
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease.
- Chia R.
- Sabir M.S.
- Bandres-Ciga S.
- Saez-Atienzar S.
- Reynolds R.H.
- Gustavsson E.
- Walton R.L.
- Ahmed S.
- Viollet C.
- Ding J.
- et al.
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
- Fernandes H.J.R.
- Hartfield E.M.
- Christian H.C.
- Emmanoulidou E.
- Zheng Y.
- Booth H.
- Bogetofte H.
- Lang C.
- Ryan B.J.
- Sardi S.P.
- et al.
Results
Novel PD iPSC-derived midbrain models demonstrate α-syn accumulation and lysosomal dysfunction
Immature GCase aggregates in the ER of patient midbrain neurons and synucleinopathy brains
ER fragmentation in SNCA-3x DA neurons that accumulate immature wild-type GCase
SNCA-3x DA neurons exhibit mild elevation of ER stress chaperones in the absence of UPR activation
α-Syn associates with ER chaperones in SNCA-3x DA neurons
Synergistic activation of ER proteostasis and trafficking rescues lysosomal function and reduces α-syn
Discussion
STAR★Methods
Key resources table
REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Rabbit polyclonal anti-alpha synuclein (C-20) | Santa Cruz | Cat #sc-7011-R; RRID: AB_2192953 |
Mouse monoclonal anti-alpha synuclein (LB509) | Abcam | Cat #ab27766; RRID: AB_727020 |
Mouse monoclonal anti-alpha synuclein (syn211) | Sigma Aldrich | Cat #S5566; RRID: AB_261518 |
Mouse monoclonal anti-alpha synuclein (303): | Biolegend | Cat #824301; RRID: AB_2564879 |
Mouse monoclonal anti-β3-tubulin | Biolegend | Cat #802001; RRID: AB_2564645 |
Rabbit polyclonal anti-calnexin (CANX) | Cell Signaling | Cat #2433S; RRID: AB_2243887 |
Mouse monoclonal anti-calnexin (CANX) (E-10) | Santa Cruz | Cat #sc-46669; RRID: AB_626784 |
Mouse monoclonal anti-cathepsin D | Sigma | Cat #C0715; RRID: AB_258707 |
Mouse monoclonal anti-EDEM1 | Santa Cruz | Cat #sc-377394 |
Rabbit polyclonal anti-p-eIF2α (ser51) | Cell Signaling | Cat #3398; RRID: AB_2096481 |
Mouse monoclonal anti-eIF2α | Santa Cruz | Cat #sc-133132; RRID: AB_1562699 |
Mouse monoclonal anti-FoxA2 | Santa Cruz | Cat #sc-101060; RRID: AB_1124660 |
Mouse monoclonal anti-GAPDH | Millipore | Cat #CB1001; RRID: AB_2107426 |
Rabbit polyclonal anti-glucocerebrosidase (GCase) | Sigma | Cat #G4171; RRID: AB_1078958 |
Mouse monoclonal anti-glucocerebrosidase (GCase) (8E4) | N/A (gift from J. Aerts): ( Barneveld et al., 1983 )
Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Human genetics. 1983; 64: 227-231 | N/A |
Rabbit polyclonal anti-GRP78 | Novus | Cat #NBP1-06274; RRID: AB_1555284 |
Mouse monoclonal anti-GRP94 | Santa Cruz | Cat #sc-393402 |
Mouse monoclonal anti-Hexosaminidase B (HexB) | Sigma | Cat #sc-376781 |
Rabbit polyclonal anti-Nanog | Abcam | Cat #ab21624; RRID: AB_446437 |
Neurofilament | Biolegend | Cat #SMI-312R; RRID: AB_2314906 |
Rabbit polyclonal anti-Oct4 | Abcam | Cat #ab19857; RRID: AB_445175 |
Rabbit polyclonal anti-PDI | Abcam | Cat #ab11432; RRID: AB_298038 |
Rabbit polyclonal anti-Sox2 | Abcam | Cat #ab97959; RRID: AB_2341193 |
Mouse monoclonal anti-SSEA4 | Abcam | Cat #ab16287; RRID: AB_778073 |
Mouse monoclonal anti-Tra-1-60 | Abcam | Cat #ab16288; RRID: AB_778563 |
Rabbit polyclonal anti-tyrosine hydroxylase (TH) | Millipore | Cat #AB5986; RRID: AB_92190 |
Rabbit polyclonal anti-ubiquitin | Dako | Cat #Z045801-5 |
Mouse monoclonal anti-ykt6 | Santa Cruz | Cat #SC-365732; RRID: AB_10859388 |
Secondary antibody: Alexa Fluor 488 Goat anti-rabbit IgG secondary (H+L) | Invitrogen | Cat #A11034; RRID: AB_2576217 |
Secondary antibody: Alexa Fluor 488 Goat anti-mouse IgG secondary (H+L) | Invitrogen | Cat #A11029; RRID: AB_138404 |
Secondary antibody: Alexa Fluor 568 Goat anti-rabbit IgG secondary (H+L) | Invitrogen | Cat #A11036; RRID: AB_10563566 |
Secondary antibody: Alexa Fluor 568 Goat anti-mouse IgG secondary (H+L) | Invitrogen | Cat #A11031; RRID: AB_144696 |
Secondary antibody: Alexa Fluor 680 Goat anti-mouse IgG secondary (H+L) | Invitrogen | Cat #A21058; RRID: AB_2535724 |
Secondary antibody: IRdye 800CW goat anti-mouse IgG secondary (H+L) | Li-Cor Biosciences | Cat #926-32210; RRID: AB_621842 |
Secondary antibody: IRdye 800CW goat anti-rabbit IgG secondary (H+L) | Li-Cor Biosciences | Cat #926-32211; RRID: AB_621843 |
Bacterial and virus strains | ||
pER4 (vector) lentivirus | Mazzulli et al., 2011 | N/A |
pER4 ykt6-CS lentivirus | Cuddy et al., 2019 | N/A |
Scrambled (scrb) shRNA lentivirus | This paper | N/A |
RyR3 shRNA lentivirus | This paper | N/A |
pER4 GBA1 L444P lentivirus | This paper | N/A |
Biological samples | ||
Human brain tissue of control, DLB, DLB + AD patients | Northwestern University Alzheimer’s disease pathology core (CNADC). Please refer to Table S1 for more details. | N/A |
Mouse Brain tissue from LIMP2−/− mice | Rothaug et al., 2014 | N/A |
Chemicals, peptides, and recombinant proteins | ||
Bafilomycin A1 | Santa Cruz | Cat #SC-201550 |
Bovine serum albumin (BSA), heat shock, fatty acid free | Roche | Cat #03117057001 |
Brefeldin A (BFA) | Cell Signaling | Cat #9972S |
Cascade Dextran Blue | Life Technologies | Cat #D1976 |
CHAPS hydrate | Sigma | Cat #C5070 |
Conduritol β epoxide (CBE) | Millipore | Cat #234599 |
Doxycycline (DOX) | Sigma | Cat #D3447 |
Diltiazem hydrochloride (DILT) | Sigma | Cat #D2521 |
Dantrolene sodium salt (DANT) | Sigma | Cat #D9175 |
DHBP (1,1’-diheptyl-4,4’-bipyridinium dibromide) | Sigma | Cat #180858 |
Epoxomicin | Fisher | Cat #10007806 |
Farnesyl transferase inhibitor (FTI): LNK-754 | Link Medicine | N/A |
Fetal bovine serum (FBS), heat-inactivated | Thermo Fisher Scientific | Cat #10438026 |
Geneticin (G418) | Thermo Fisher Scientific | Cat #10131027 |
L-glutamine | GIBCO | Cat #25030081 |
Glutaraldehyde, 25% aqueous solution | Electron Microscopy Sciences | Cat #16220 |
Hygromycin B | Thermo Fisher Scientific | Cat #10687010 |
LX112 | Ladd Research Industries | Cat #21310 |
Normal goat serum (NGS) | Jackson ImmunoResearch | Cat #005-000-121 |
Osmium tetroxide (OsO4), 4% aqueous solution | Electron Microscopy Sciences | Cat #19150 |
Paraformaldehyde (10%, methanol-free) | Polysciences, Inc. | Cat #40181 |
Penicillin / Streptomycin | Thermo Fisher Scientific | Cat #10378016 |
Phenylmethylsulfonyl fluoride (PMSF) | Sigma | Cat #78830 |
Protease Inhibitor Cocktail (PIC) | Roche | Cat #11836170001 |
N-Lauroylsarcosine sodium salt (sarkosyl) | Sigma | Cat #L9150 |
Sodium dodecyl sulfate (SDS) | Sigma | Cat #L4509 |
Sodium orthovanadate (Na3VO4) | Sigma | Cat #450243 |
Sodium fluoride (NaF) | Sigma | Cat #201154 |
Sucrose | Sigma | Cat #S1888 |
Triton X-100 | Sigma | Cat #T8787 |
Thapsigargin (Tg) | Sigma | Cat #T9033 |
Thioflavin S (ThioS) | Sigma | Cat #T1892 |
Uranyl acetate | Electron Microscopy Sciences | Cat #22400 |
Methyl-5-Norbornene-2,3-Dicarboxylic Anhydride (NMA) | Electron Microscopy Sciences | Cat #19000 |
Dodecenyl Succinic Anhydride (DDSA): | Electron Microscopy Sciences | Cat #13700 |
2,4,6-Tri(dimethylaminomethyl) phenol (DMP-30) | Electron Microscopy Sciences | Cat #13600 |
5-(pentafluoro-benzoylamino) fluorescein di-β-D-glucopyranoside (PFB-FDGluc) | Life Technologies | Cat #P11947 |
4-methylumbelliferyl β-glucopyranoside (4-MU-Gluc) | Chem-Impex Int’l Inc. | Cat #21630 |
Critical commercial assays | ||
CellTag 700 | Li-Cor Biosciences | Cat #926-41090 |
Concanavalin A (CON-A), biotinylated | Vector Laboratories | Cat #B-1005-5 |
DNeasy Blood and Tissue Kit | QIAGEN | Cat #69504 |
Duolink In Situ Red Starter Kit Mouse/Rabbit | Sigma Aldrich | Cat #92101 |
Endoglycosidase H | New England Biolabs | Cat #P0702L |
HIV1-p24 Antigen ELISA Kit | Zeptometrix | Cat #0801111 |
Pierce BCA Protein Assay Kit | Thermo Fisher Scientific | Cat #23227 |
PureLink Genomic DNA Kit | Invitrogen | Cat #K182002 |
RevertAid First Strand cDNA Synthesis Kit | Thermo Fisher Scientific | Cat #K1621 |
RNeasy Mini Prep Kit | QIAGEN | Cat #74104 |
T7EI Endonuclease I assay kit | Genecopoeia | Cat #IC005 |
Quantitative RT-PCR: SNCA (ID: Hs00240906_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: GRP78 (ID: Hs99999174_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: CANX (ID: Hs01558409_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: EDEM1 (ID: Hs00976004_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: XBP1-S (ID: Hs03929085_g1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: RyR3 (ID: Hs00168821_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: GBA1 (ID: Hs00164683_m1) | Thermo Fisher Scientific | Cat #433118 |
Quantitative RT-PCR: Nanog (ID: Hs04399610_g1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: Puromycin (Custom Assay# gi763524_CCN1FIY) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: RNaseP (ID: 4403326) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: ACTB (β-actin) (ID: Hs99999903_m1) | Thermo Fisher Scientific | Cat #4331182 |
Quantitative RT-PCR: GAPDH (ID: Hs02758991_g1) | Thermo Fisher Scientific | Cat #4331182 |
QuikChange XL Site-Directed Mutagenesis Kit | Agilent | Cat #200517 |
Deposited Data | ||
Raw western blot images | Mendeley | Mendeley Data: https://doi.org/10.17632/29t6p4wrs7.1 |
Experimental models: Cell lines | ||
H4 neuroglioma cells | Mazzulli et al., 2011 ; From: Pamela McLean (Mayo Clinic, Jacksonville, Florida, USA) | N/A |
GM15010 (SNCA Triplication, 3x-1) | This paper; clinical and other information can be obtained from the Coriell Cell Repository | N/A |
ND00196 (SNCA Triplication, 3x-2) | This paper; clinical and other information can be obtained from the Coriell Cell Repository | N/A |
ND00139 (SNCA Triplication, 3x-4) | This paper; clinical and other information can be obtained from the Coriell Cell Repository | N/A |
ND34391 (SNCA Triplication, Est. 3X). | Mazzulli et al., 2016 ; Zunke et al., 2018 ; Cuddy et al., 2019 ; Coriell Cell Repository | N/A |
GM00852, GD patient (N370S / 84GG) | Mazzulli et al., 2011 ; Mazzulli et al., 2016 ; Coriell Cell Repository | N/A |
ND34982, GBA1-PD heterozygote (N370S / WT) | Coriell Cell Repository | N/A |
GD patient L444P / L444P | ( Schöndorf et al., 2014 )
iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis. Nat Commun. 2014; https://doi.org/10.1038/ncomms5028 | N/A |
A53T alpha-synuclein and isogenic control | Soldner et al., 2011 | N/A |
Oligonucleotides | ||
See Table S4 | N/A | |
Recombinant DNA | ||
pCXLE-hOCT3/4-shp53-F | Addgene, ( Okita et al., 2011 ) | Cat #27077 |
pCXLE-hUL | Addgene, ( Okita et al., 2011 ) | Cat #27080 |
pCXLE-hSK | Addgene, ( Okita et al., 2011 ) | Cat #27078 |
PITX3-2A-eGFP-PGK-Puro | Addgene, ( Hockemeyer et al., 2011 ) | Cat #31943 |
Cas9-nickase plasmid PX335 | Addgene, ( Nora et al., 2017 ) | Cat #42335 |
pLKO.1 RyR3 shRNA (clone ID #TRCN0000053349) | Sigma | Cat #NM_001036 |
pER4-ykt6-CS | This paper | N/A |
pER4-GBA1 L444P | This paper | N/A |
Software and algorithms | ||
GraphPad Prism V6.0 software | GraphPad | https://www.graphpad.com/scientific-software/prism/: |
ImageJ / Fiji V1.0 software | National Institutes of Health | https://imagej.net/software/fiji/ |
Nikon NIS Elements | Nikon | https://www.microscope.healthcare.nikon.com/products/software/nis-elements |
Odyssey software (Image Studio V3.1.4) | Li-Cor Biosciences | https://www.licor.com/bio/image-studio/ |
Snapgene V5.3 software | SnapGene | https://www.snapgene.com |
Other | ||
Concanavalin-A, biotinylated | Vector Laboratories | Cat #B-1005-5 |
DAPI Fluoromount mounting media | Southern Biotech | Cat #0100-20 |
Intercept blocking buffer | Li-Cor Biosciences | Cat #927-70001 |
Lenti-X concentrator | Clontech | Cat #631232 |
Lipofectamine 3000 | Thermo Fisher Scientific | Cat #L3000008 |
Matrigel | Fisher | Cat #CB-40234 |
mTeSR1 media | StemCell Technologies | Cat #85850 |
Neurobasal SM1 media | Thermo Fisher Scientific | Cat #21103-049 |
NeuroCult SM1 supplement: | StemCell Technologies | Cat #05711 |
NeutrAvidin agarose beads | Thermo Fisher Scientific | Cat #29204 |
PVDF transfer membrane, 0.45 μm pore size | Millipore | Cat #IPFL00010 |
X-tremeGENE HP DNA Transfection Reagent | Roche | Cat #6366236001 |
Resource availability
Lead contact
Materials availability
Experimental model and subject details
Human H4 neuroglioma cell culture
iPSC model generation, characterization and culture methods
Reprogramming and culturing of human induced pluripotent stem cells (iPSCs)
Pluripotency analysis of reprogrammed iPSC cells
I. Immunofluorescence analysis of pluripotency markers
II. PCR analysis of reprogramming factor transgenes
Quantitative RT-PCR
Copy number analysis of SNCA and puromycin
Fluorescence in situ hybridization (FISH) analysis
Differentiation of iPSCs into midbrain dopaminergic neurons
Dual nickase CRISPR/Cas9 strategy and selection of iPSC clones
Analysis of off-target effects using the T7EI cleavage assay
Method details
Biochemistry and Molecular Biology
Sequential protein extraction and western blotting analysis
Co-immunoprecipitation
Sequential extraction analysis of LIMP2 knock-out mice
Live-cell lysosomal GCase activity assay
In vitro whole-cell lysate GCase activity assay
Endoglycosidase H (Endo H) digestion
Insoluble hydrolase analysis of synucleinopathy brain tissues
Insoluble GCase analysis of ER microsome-enriched idiopathic PD brain tissues
GBA1 mutation genotyping of human brain samples
ER microsome-enrichment of iPSC-derived neurons
Semiquantitative RT-PCR analysis of XBP1 mRNA
Assessment of calnexin activity by Concanavalin-A pulldown
Imaging analysis
Immunofluorescence analysis of midbrain neuron differentiation efficiency, α-synuclein accumulation, and thioflavin staining
Measurement of Neuron viability through neurofilament quantification
Electron Microscopy (EM) analysis
Proximity Ligation Assay (PLA)
Super-resolution structured illumination microscopy (SIM)
Pharmacological treatment of cell cultures
ER stress induction of H4 cells or iPSC neurons
Proteasomal inhibition of iPSC neurons
Treatment of H4 cells or iPSC neurons with ER proteostasis and trafficking enhancers
Lentiviral treatment of cell cultures
Lentiviral preparation and transduction of H4 cells and iPSC neurons
Ryanodine receptor RyR3 knockdown using shRNA constructs
Generation of the GBA1 L444P plasmid and transduction in iPSC-neurons
Quantification and statistical analysis
Data and code availability
- •Data availability: All data reported in this paper will be shared by the lead contact upon request. Raw image files are avialable at Mendeley Data: http://doi.org/10.17632/29t6p4wrs7.1.
- •Code: This paper does not report original code.
- •Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.
Acknowledgments
Author contributions
Declaration of interests
Supplemental information
- Document S1. Figures S1–S8
- Table S1. Clinical, pathological, and raw western blot data from human brain analysis of insoluble GCase, related to Figure 2
- Table S2. Clinical, pathological, and raw western blot data from human brain microsome fractionation, related to Figure 2
- Table S3. Raw western blot data from human brain analysis on insoluble cathepsin D, related to Figure 2
- Table S4. Oligonucleotide sequences used in this study, related to Figures S1, S2, and S4 and Table S1
References
- Defects in trafficking bridge Parkinson’s disease pathology and genetics.Nature. 2016; 539: 207-216
- Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.Neuron. 2000; 25: 239-252
- Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies.Human genetics. 1983; 64: 227-231
- Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson’s disease.J. Neurochem. 2011; 116: 588-605
- Perturbation of cellular calcium induces secretion of luminal ER proteins.Cell. 1989; 59: 729-737
- IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA.Nature. 2002; 415: 92-96
- A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci.Nat. Genet. 2017; 49: 1511-1516
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.Nat. Genet. 2021; 53: 294-303
- Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.Science. 2013; 342: 983-987
- Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.J. Neurosci. 2012; 32: 3306-3320
- Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo.J. Neurosci. 2012; 32: 3301-3305
- Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.Neurobiol. Dis. 2018; 111: 36-47
- Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.Nat. Med. 1998; 4: 1318-1320
- Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models.Science. 2006; 313: 324-328
- α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson’s disease.Neurobiol. Dis. 2015; 76: 112-125
- Analysis of lysosomal hydrolase trafficking and activity in human iPSC-derived neuronal models.STAR Protoc. 2021; 2: 100340
- Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.Neuron. 2019; 104: 869-884.e11
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson’s iPSC-Derived Dopamine Neurons.Stem Cell Reports. 2016; 6: 342-356
- Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors.J. Biol. Chem. 1997; 272: 26965-26971
- Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.Neurology. 2007; 68: 916-922
- Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum.J. Biol. Chem. 1988; 263: 18545-18552
- N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson’s disease.Mov. Disord. 2017; 32: 1409-1422
- The Parkinson’s disease protein alpha-synuclein disrupts cellular Rab homeostasis.Proc. Natl. Acad. Sci. USA. 2008; 105: 145-150
- Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.Mol. Ther. 2012; 20: 1327-1337
- Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion.J. Biol. Chem. 2002; 277: 48984-48992
- Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogramming.Nat. Chem. Biol. 2020; 16: 1052-1061
- α-Synuclein is localized to mitochondria-associated ER membranes.J. Neurosci. 2014; 34: 249-259
- Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase.Nature. 1999; 397: 271-274
- Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF.Nature. 1992; 360: 352-354
- Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons.Hum. Mol. Genet. 2017; 26: 4441-4450
- A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.Sci. Transl. Med. 2019; 11: eaat3005
- Genetic engineering of human pluripotent cells using TALE nucleases.Nat Biotechnol. 2011; 29: 731-734
- Activation of the unfolded protein response in Parkinson’s disease.Biochem. Biophys. Res. Commun. 2007; 354: 707-711
- Impaired intracellular trafficking defines early Parkinson’s disease.Trends Neurosci. 2015; 38: 178-188
- Effects of bipyridylium compounds on calcium release from triadic vesicles isolated from rabbit skeletal muscle.Br. J. Pharmacol. 1994; 112: 1216-1222
- Is Parkinson’s disease a lysosomal disorder?.Brain. 2018; 141: 2255-2262
- The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins.Nature. 1988; 332: 462-464
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease.Nature. 2011; 480: 547-551
- XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response.Mol. Cell. Biol. 2003; 23: 7448-7459
- Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum.J. Cell Biol. 1992; 117: 505-513
- LRRK2 pathobiology in Parkinson’s disease.J. Neurochem. 2014; 131: 554-565
- Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.Science. 2000; 287: 1265-1269
- Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.Cell. 2011; 146: 37-52
- α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.Proc. Natl. Acad. Sci. USA. 2016; 113: 1931-1936
- Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum.Nature. 1994; 370: 373-375
- Chemical and biological approaches synergize to ameliorate protein-folding diseases.Cell. 2008; 134: 769-781
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease.Nat. Genet. 2014; 46: 989-993
- Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization.Cell. 2017; 169: 930-944.e22
- A more efficient method to generate integration-free human iPS cells.Nat Methods. 2011; 8: 409-412
- Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis.Nat. Chem. Biol. 2010; 6: 424-432
- Association of folding intermediates of glycoproteins with calnexin during protein maturation.Nature. 1993; 364: 771-776
- α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production.Acta Neuropathol. 2017; 134: 129-149
- Brefeldin A, thapsigargin, and AIF4- stimulate the accumulation of GRP78 mRNA in a cycloheximide dependent manner, whilst induction by hypoxia is independent of protein synthesis.J. Cell. Physiol. 1992; 152: 545-552
- Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.Proc. Natl. Acad. Sci. USA. 1982; 79: 6360-6364
- Retention of unassembled components of integral membrane proteins by calnexin.Science. 1994; 263: 387-390
- LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.Cell. 2007; 131: 770-783
- Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease.Brain. 2017; 140: 3191-3203
- ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.Hum. Mol. Genet. 2005; 14: 2387-2398
- The Spectrum of Neurological Manifestations Associated with Gaucher Disease.Diseases. 2017; 5: E10
- LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.Proc. Natl. Acad. Sci. USA. 2014; 111: 15573-15578
- iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis.Nat Commun. 2014; https://doi.org/10.1038/ncomms5028
- Membrane expansion alleviates endoplasmic reticulum stress independently of the unfolded protein response.J. Cell Biol. 2009; 187: 525-536
- Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease.N. Engl. J. Med. 2009; 361: 1651-1661
- Genome-wide association study reveals genetic risk underlying Parkinson’s disease.Nat. Genet. 2009; 41: 1308-1312
- Parkinson’s: A Disease of Aberrant Vesicle Trafficking.Annu. Rev. Cell Dev. Biol. 2020; 36: 237-264
- alpha-Synuclein locus triplication causes Parkinson’s disease.Science. 2003; 302: 841
- Road to ruin: targeting proteins for degradation in the endoplasmic reticulum.Science. 2011; 334: 1086-1090
- Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.Cell. 2011; 146: 318-331
- Alpha-synuclein in Lewy bodies.Nature. 1997; 388: 839-840
- Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue.STAR Protoc. 2021; 2: 100372
- In vivo and ex vivo evaluation of L-type calcium channel blockers on acid beta-glucosidase in Gaucher disease mouse models.PLoS ONE. 2009; 4: e7320
- ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher’s disease.Chem. Biol. 2014; 21: 967-976
- Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs.Mol. Biol. Cell. 2010; 21: 1850-1863
- Enforced dimerization between XBP1s and ATF6f enhances the protective effects of the UPR in models of neurodegeneration.Mol. Ther. 2021; 29: 1862-1882
- The unfolded protein response: from stress pathway to homeostatic regulation.Science. 2011; 334: 1081-1086
- Protein misfolding in the endoplasmic reticulum as a conduit to human disease.Nature. 2016; 529: 326-335
- Ca2+ homeostasis modulation enhances the amenability of L444P glucosylcerebrosidase to proteostasis regulation in patient-derived fibroblasts.ACS Chem. Biol. 2011; 6: 158-168
- Multiple lysosomal enzyme deficiency due to enzyme leakage?.N. Engl. J. Med. 1971; 284: 109-110
- XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.Cell. 2001; 107: 881-891
- Modeling neuronopathic storage diseases with patient-derived culture systems.Neurobiol. Dis. 2019; 127: 147-162
- Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide.Neuron. 2018; 97: 92-107.e10
Article info
Publication history
Identification
Copyright
User license
Elsevier user license |Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy